Julie Baker

Ms. Baker brings over 30 years of commercial pharmaceutical experience including building and leading marketing teams, product and lifecycle management, brand strategy, and payer marketing. Most recently, Ms. Baker served as VP of Marketing for the Epilepsy Business Unit of Jazz Pharmaceuticals, having been VP of Marketing for Greenwich Biosciences at the time of the acquisition (acquired by Nasdaq: JAZZ for $7.2 Billion). During her tenure, she led the most successful commercial product launch in the rare, refractory epilepsy space to date, and served as the global development team commercial lead. Ms. Baker spent over 15 years at Pfizer, supporting the launch of multiple blockbuster medicines and establishing payer marketing. Over the course of her career, she held marketing roles in biotech start-ups including Otonomy and MannKind, as well as leading marketing for a business unit of animal health leader, Zoetis. Ms. Baker received her B.B.A. in Marketing at The George Washington University and an M.B.A. from New York University.